CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net Income (Loss)	$ (1,781)	$ (2,387)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	421	329
Stock-based compensation expense	209	598
Credit loss, net of recoveries	267	496
Gain on disposition of assets	0	(2)
Noncash amortization of debt discount	49	136
Noncash change in fair value of derivatives	(10)	(14)
Other	0	1
Changes in operating assets and liabilities:
Accounts receivable	(173)	(13)
Prepaid expenses and other current assets	(426)	266
Accounts payable	491	(173)
Accrued expenses and other current liabilities	(995)	(223)
Deferred revenue	86	113
Net cash used in operating activities	(1,862)	(873)
Cash flows from investing activities
Additions of property, equipment, and software	(349)	(211)
Proceeds from sale of property and equipment	0	2
Net cash used in investing activities	(349)	(209)
Cash flows from financing activities
Issuance of common stock under ESPP	0	16
Tax payments related to shares retired for vested restricted stock units	(2)	(40)
Repayments of related party payables	0	(90)
Repayments of convertible notes	(3,678)	0
Net cash used in financing activities	(3,680)	(114)
Net decrease in cash, cash equivalents, and restricted cash	(5,891)	(1,196)
Cash, cash equivalents, and restricted cash, beginning of period	14,772	15,544
Cash, cash equivalents, and restricted cash, end of period	8,881	14,348
Supplemental disclosure of non-cash financing activities
Short-term financing of insurance payable	$ 0	$ (1,399)